325 related articles for article (PubMed ID: 29115935)
21. Characterization of HOX gene expression in canine mammary tumour cell lines from spontaneous tumours.
DeInnocentes P; Perry AL; Graff EC; Lutful Kabir FM; Curtis Bird R
Vet Comp Oncol; 2015 Sep; 13(3):322-36. PubMed ID: 24034269
[TBL] [Abstract][Full Text] [Related]
22. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
[TBL] [Abstract][Full Text] [Related]
23. Global gene expression profile in canine mammary carcinomas.
Varallo GR; Jardim-Perassi BV; Alexandre PA; Fukumasu H; Zuccari DAPC
Vet J; 2019 Dec; 254():105393. PubMed ID: 31836163
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer.
Yoo B; Meka N; Sheedy P; Billig AM; Pantazopoulos P; Medarova Z
PLoS One; 2019; 14(12):e0226356. PubMed ID: 31834924
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
26. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
[TBL] [Abstract][Full Text] [Related]
27. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
Ahern TE; Bird RC; Bird AE; Wolfe LG
Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.
Moschetta MG; Maschio LB; Jardim-Perassi BV; Gelaleti GB; Lopes JR; Leonel C; Gonçalves Ndo N; Ferreira LC; Martins GR; Borin TF; Zuccari DA
Oncol Rep; 2015 May; 33(5):2345-53. PubMed ID: 25779537
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA expression in canine mammary cancer.
Boggs RM; Wright ZM; Stickney MJ; Porter WW; Murphy KE
Mamm Genome; 2008 Aug; 19(7-8):561-9. PubMed ID: 18665421
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.
Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107
[TBL] [Abstract][Full Text] [Related]
31. Circulating microRNA-214 and -126 as potential biomarkers for canine neoplastic disease.
Heishima K; Ichikawa Y; Yoshida K; Iwasaki R; Sakai H; Nakagawa T; Tanaka Y; Hoshino Y; Okamura Y; Murakami M; Maruo K; Akao Y; Mori T
Sci Rep; 2017 May; 7(1):2301. PubMed ID: 28536479
[TBL] [Abstract][Full Text] [Related]
32. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
33. Unravelling site-specific breast cancer metastasis: a microRNA expression profiling study.
Schrijver WA; van Diest PJ; ; Moelans CB
Oncotarget; 2017 Jan; 8(2):3111-3123. PubMed ID: 27902972
[TBL] [Abstract][Full Text] [Related]
34. Comparative expression pathway analysis of human and canine mammary tumors.
Uva P; Aurisicchio L; Watters J; Loboda A; Kulkarni A; Castle J; Palombo F; Viti V; Mesiti G; Zappulli V; Marconato L; Abramo F; Ciliberto G; Lahm A; La Monica N; de Rinaldis E
BMC Genomics; 2009 Mar; 10():135. PubMed ID: 19327144
[TBL] [Abstract][Full Text] [Related]
35. Defect of the mitochondrial DNA hypervariable region as a risk factor for canine mammary tumour.
Surdyka M; Slaska B
Vet Comp Oncol; 2017 Sep; 15(3):820-828. PubMed ID: 27198058
[TBL] [Abstract][Full Text] [Related]
36. EGFR and microvessel density in canine malignant mammary tumours.
Carvalho MI; Guimarães MJ; Pires I; Prada J; Silva-Carvalho R; Lopes C; Queiroga FL
Res Vet Sci; 2013 Dec; 95(3):1094-9. PubMed ID: 24091029
[TBL] [Abstract][Full Text] [Related]
37. miR-497 induces apoptosis by the IRAK2/NF-κB axis in the canine mammary tumour.
Zhang T; Feng X; Zhou T; Zhou N; Shi X; Zhu X; Qiu J; Deng G; Qiu C
Vet Comp Oncol; 2021 Mar; 19(1):69-78. PubMed ID: 32706167
[TBL] [Abstract][Full Text] [Related]
38. Expression frequency of c-kit isoforms and its prognostic potential in canine mammary tumours.
Chen YC; Liao JW; Chang SC; Hsu WL
Vet Comp Oncol; 2020 Sep; 18(3):303-314. PubMed ID: 31652393
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors.
Rao NA; van Wolferen ME; Gracanin A; Bhatti SF; Krol M; Holstege FC; Mol JA
J Physiol Pharmacol; 2009 May; 60 Suppl 1():73-84. PubMed ID: 19609016
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA expression profiling in canine prostate cancer.
Kobayashi M; Saito A; Tanaka Y; Michishita M; Kobayashi M; Irimajiri M; Kaneda T; Ochiai K; Bonkobara M; Takahashi K; Hori T; Kawakami E
J Vet Med Sci; 2017 Apr; 79(4):719-725. PubMed ID: 28239051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
